Log in to save to my catalogue

Assessment and management of disease burden and quality of life in patients with hereditary angioede...

Assessment and management of disease burden and quality of life in patients with hereditary angioede...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_852737c8b7524b67a4607b838b668854

Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report

About this item

Full title

Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report

Publisher

England: BioMed Central Ltd

Journal title

Allergy, asthma, and clinical immunology, 2021-04, Vol.17 (1), p.40-40, Article 40

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Hereditary angioedema (HAE) is a rare disease characterized by unpredictable, potentially life-threatening attacks, resulting in significant physical and emotional burdens for patients and families. To optimize care for patients with HAE, an individualized management plan should be considered in partnership with the physician, requiring comprehensi...

Alternative Titles

Full title

Assessment and management of disease burden and quality of life in patients with hereditary angioedema: a consensus report

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_852737c8b7524b67a4607b838b668854

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_852737c8b7524b67a4607b838b668854

Other Identifiers

ISSN

1710-1484,1710-1492

E-ISSN

1710-1492

DOI

10.1186/s13223-021-00537-2

How to access this item